Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
human complement component C1 + H2O | Pseudomonas aeruginosa | - |
? | - |
? | |
human complement component C2 + H2O | Pseudomonas aeruginosa | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Pseudomonas aeruginosa | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
human complement component C1 + H2O | - |
Pseudomonas aeruginosa | ? | - |
? | |
human complement component C2 + H2O | - |
Pseudomonas aeruginosa | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
AprA | - |
Pseudomonas aeruginosa |
Pseudomonas aeruginosa alkaline protease | - |
Pseudomonas aeruginosa |
General Information | Comment | Organism |
---|---|---|
physiological function | the alkaline protease AprA is associated with bacterial virulence and interferes with complement-mediated lysis of erythrocytes and complement activation. AprA potently blocks phagocytosis and killing of Pseudomonas by human neutrophils. AprA inhibits opsonization of bacteria with C3b and the formation of the chemotactic agent C5a. AprA specifically blocks C3b deposition via the classical and lectin pathways, whereas the alternative pathway is not affected. AprA degrades both human C1s and C2, and the mechanism of action for complement inhibition is cleavage of C2, overview | Pseudomonas aeruginosa |